VINCERE BIOSCIENCES
Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).
VINCERE BIOSCIENCES
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vincerebio.com
Total Employee:
1+
Status:
Active
Total Funding:
1.75 M USD
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset
Similar Organizations
Mavalon Therapeutics
Mavalon is developing drugs to stop the progression of Parkinson's disease.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Advisors List
Current Employees Featured
Founder
Investors List
Daewoong Pharmaceutical
Daewoong Pharmaceutical investment in Corporate Round - Vincere Biosciences
HanAll Biopharma
HanAll Biopharma investment in Corporate Round - Vincere Biosciences
Healthspan Capital
Healthspan Capital investment in Seed Round - Vincere Biosciences
Viva BioInnovator
Viva BioInnovator investment in Seed Round - Vincere Biosciences
JLABS
JLABS investment in Seed Round - Vincere Biosciences
Alumni Ventures
Alumni Ventures investment in Seed Round - Vincere Biosciences
Official Site Inspections
http://www.vincerebio.com
- Host name: 137.135.107.11
- IP address: 137.135.107.11
- Location: Washington United States
- Latitude: 38.7095
- Longitude: -78.1539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 22747
More informations about "Vincere Biosciences"
Vincere Biosciences
Vincere makes new medicines to treat age-related diseases including Parkinson’s and Kidney disease. Our work is backed by top agencies such as the National Institutes of Health and the …See details»
Vincere Biosciences
Vincere Biosciences. Meet the Team. Spring Behrouz, PhD. Chairman, & CEO. Role: Sets vision and direction for company. Experience: Over 15 years working on Parkinson's disease.See details»
Vincere Biosciences - LinkedIn
Vincere Biosciences is dedicated to conquering age-related diseases through the development of small molecule therapeutics empowered by a suite of computational tools alongside traditional...See details»
Vincere Biosciences
Vincere to Attend the RESI Conference 2023. Boston, MA - September 2023: Vincere Biosciences will be attending the RESI (Redefining Early Stage Investments) Conference, held in Boston. The event is a premier platform that …See details»
Vincere Biosciences - Crunchbase Company Profile
Vincere Biosciences is a JLABS incubator company whose mission is to develop drugs to halt the progression of Parkinson's disease (PD).See details»
Vincere Biosciences, Inc. - VentureRadar
Website: http://www.vincerebio.com. Vincere develops small molecule therapeutics to improve mitochondrial quality. Natural mechanisms of mitochondrial quality control decline with age, …See details»
MitoWorld
Vincere Biosciences. Mission Statement. At Vincere Biosciences, our cutting-edge research focuses on the vital role of mitophagy in both Parkinson’s disease and the aging process. By …See details»
Vincere Biosciences Company Profile 2024: Valuation, Funding ...
Vincere Biosciences Overview. Update this profile. Year Founded. 2018. Status. Private. Employees. 10. Latest Deal Type. 2ndary - Private. Investors. 12. General Information. …See details»
Vincere Biosciences, Inc. Company Profile - Dun & Bradstreet
Overview. Company Description: Key Principal: Bahareh Behrouz See more contacts. Industry: Scientific Research and Development Services , Professional, Scientific, and Technical …See details»
Vincere Biosciences Inc - BIO International Convention | BIO - bio.org
Jun 7, 2023 · Vincere Biosciences, Inc. The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member …See details»
NIA Small Business Showcase: Vincere Biosciences
Jan 9, 2024 · NIA Small Business Showcase: Vincere Biosciences. Vincere Biosciences is tackling the challenge of age-related decline, starting with enhancement of mitophagy, a mechanism known to decline with age …See details»
Vincere Bio's Leadership Team Team - Team members and org …
The leadership team at Vincere Bio has experience in a variety of industries, including technology, finance, and healthcare. They have also received education from some of the top universities …See details»
Vincere Biosciences: Contact Details and Business Profile
Vincere Biosciences is dedicated to conquering age-related diseases through the development of small molecule therapeutics empowered by a suite of computational tools alongside traditional …See details»
Vincere Biosciences Receives Funding from The Michael J. Fox …
Cambridge, MA, USA - August 29 2022: Vincere Biosciences has been awarded a $400,000 grant from The Michael J. Fox Foundation for Parkinson’s Disease (MJFF) - in collaboration with the …See details»
Vincere Biosciences - Viva BioInnovator
Biology is complex with a rapidly growing body of knowledge. Proprietary simulation and AI from NeuroInitiative enables the Vinere team to move faster and synthesize new discoveries into …See details»
Vincere Biosciences - Craft
Vincere Biosciences is a company that develops disease-modifying therapies for Parkinson's disease. It provides medications that can restore mitochondrial quality to slow the progression …See details»
Vincere Biosciences
Join the team! Vincere Biosciences is a Cambridge, MA, company developing disease-modifying therapies for Parkinson's disease. While the team is intentionally small, we do periodically …See details»
FreeMind Investments (FMI) update: Daewoong Pharmaceuticals, …
Jun 12, 2023 · Vincere Biosciences aims to conquer degeneration, whether in Parkinson’s or age-related degeneration, through the discovery and development of small molecules empowered …See details»
Vincere Biosciences
Vincere Biosciences | Enhancing Mitophagy - Protecting Energetically Demanding Tissues.See details»
PR Vincere_VAI NIH grant.docx
Cambridge, MA, USA - September 25, 2023: Vincere Biosciences, Inc., a biotech focused on neurodegenerative disease therapeutics, has been awarded a Phase I Small Business …See details»